Blog

Aug 2, 2024, 01:47

Sergio Cifuentes Canaval: Neoadjuvant Chemo-Immuno for ER+ HER- breast cancer

Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent paper by Alejandro Ríos-Hoyo et al., titled “Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer” published on Journal of Clinical Oncology.

Authors: Alejandro Ríos-Hoyo, Erin Cobain, Laura A. Huppert, Peter D. Beitsch, Thomas A. Buchholz, Laura Esserman, Laura J. van ‘t Veer, Hope S. Rugo, Lajos Pusztai.

“Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer
– Congratulations to Alejandro Ríos-Hoyo.”

Source: Sergio Cifuentes Canaval/LinkedIn

Alejandro Ríos-Hoyo Breast Cancer cancer Erin Cobain Estrogen Receptor–Positive Human Epidermal Growth Factor 2 Hope S. Rugo Journal of Clinical Oncology Lajos Pusztai Laura A. Huppert Laura Esserman Laura J. van ‘t Veer OncoDaily Oncology Peter D. Beitsch Sergio Cifuentes Canaval Thomas A. Buchholz

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

Special Coverage